Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation

Clinical trial NCT02411019 · UNKNOWN

Trial details

NCT number: NCT02411019
Sponsor: Genexine, Inc.
Status: UNKNOWN
Study type: OBSERVATIONAL

Cervical Intraepithelial Neoplasia 3

Start date: 2015-03-01
Primary completion: 2018-11-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.